New horizons for the therapeutic application of nanozymes in cancer treatment
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 20, 2025
The
advent
of
nanozymes
has
revolutionized
approaches
to
cancer
diagnosis
and
therapy,
introducing
innovative
strategies
that
address
the
limitations
conventional
treatments.
Nanozyme
nanostructures
with
enzyme-mimicking
catalytic
abilities
exhibit
exceptional
stability,
biocompatibility,
customizable
functions,
positioning
them
as
promising
tools
for
theranostics.
By
emulating
natural
enzyme
reactions,
can
selectively
target
eradicate
cells,
minimizing
harm
adjacent
healthy
tissues.
Nanozymes
also
be
functionalized
specific
targeting
ligands,
allowing
precise
delivery
regulated
release
therapeutic
agents,
improving
treatment
effectiveness
reducing
adverse
effects.
However,
issues
such
selectivity,
regulatory
compliance
remain
critical
challenges
clinical
application
nanozymes.
This
review
provides
an
overview
nanozymes,
highlighting
their
unique
properties,
various
classifications,
activities,
diverse
applications
in
strategic
oncological
deployment
could
profoundly
impact
future
advancements
personalized
medicine,
recent
progress
prospective
directions
enzyme-mimetic
treatment.
summarizes
Language: Английский
Interlayer-engineered “six-in-one” nanozymes for cascade enzymatic/photothermal oncotherapy
Zhenli Zhou,
No information about this author
Danyang Li,
No information about this author
Linke Yu
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 159189 - 159189
Published: Jan. 1, 2025
Language: Английский
Herbacetin as a Novel Ferroptosis Inhibitor for Mitigating Myocardial Damage Induced by Doxorubicin
Hai Yang,
No information about this author
Shaohong Huang,
No information about this author
Xinyu Heng
No information about this author
et al.
Published: Jan. 1, 2025
Language: Английский
The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury
Chih-Jen Liu,
No information about this author
Lu‐Kai Wang,
No information about this author
Fu‐Ming Tsai
No information about this author
et al.
Current Issues in Molecular Biology,
Journal Year:
2025,
Volume and Issue:
47(3), P. 176 - 176
Published: March 7, 2025
Chemotherapeutic
agents
play
a
crucial
role
in
cancer
treatment.
However,
their
use
is
often
associated
with
significant
adverse
effects,
particularly
cardiotoxicity.
Drugs
such
as
anthracyclines
(e.g.,
doxorubicin)
and
platinum-based
cisplatin)
cause
mitochondrial
damage,
which
one
of
the
main
mechanisms
underlying
These
drugs
induce
oxidative
stress,
leading
to
an
increase
reactive
oxygen
species
(ROS),
turn
damage
mitochondria
cardiomyocytes,
resulting
impaired
cardiac
function
heart
failure.
Mitochondria-targeted
antioxidants
(MTAs)
have
emerged
promising
cardioprotective
strategy,
offering
potential
solution.
efficiently
scavenge
ROS
within
mitochondria,
protecting
cardiomyocytes
from
damage.
Recent
studies
shown
that
MTAs,
elamipretide,
SkQ1,
CoQ10,
melatonin,
significantly
mitigate
chemotherapy-induced
not
only
reduce
but
also
help
maintain
structure
function,
stabilize
membrane
potential,
prevent
excessive
opening
permeability
transition
pore,
thus
preventing
apoptosis
dysfunction.
In
this
review,
we
integrate
recent
findings
elucidate
cardiotoxicity
highlight
substantial
therapeutic
MTAs
reducing
are
expected
offer
safer
more
effective
treatment
options
for
patients
clinical
practice.
Language: Английский
Bimetallic NiCu‐MOF Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Suppressing Ferroptosis and Inflammation
Lu Liu,
No information about this author
Daiyong Chao,
No information about this author
Qing Dong
No information about this author
et al.
Advanced Healthcare Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 18, 2025
Abstract
Doxorubicin
(DOX),
a
potent
anthracycline
chemotherapeutic
agent,
is
widely
used
in
cancer
treatment
but
associated
with
significant
adverse
effects,
particularly
DOX‐induced
cardiomyopathy
(DIC).
DIC
pathogenesis
involves
the
generation
of
reactive
oxygen
species
(ROS)
and
ferroptosis
induction.
Novel
therapeutic
strategies
targeting
antioxidant
defenses
inhibition
are
essential
for
mitigating
DIC.
An
innovative
bimetallic
metal‐organic
framework
(MOF),
NiCu‐MOF
(NCM),
developed,
exhibiting
multifaceted
enzyme‐mimicking
activities
that
effectively
scavenge
broad
spectrum
ROS.
Additionally,
NCM
exhibits
excellent
iron‐chelating
ability.
In
vitro
experiments
demonstrate
significantly
reduces
cardiomyocyte
death
by
attenuating
ROS
levels
inhibiting
ferroptosis.
Furthermore,
mouse
model
DIC,
results
substantial
myocardial
protection,
evidenced
improved
cardiac
function
structural
integrity.
This
protective
effect
attributed
to
suppression
ferroptosis,
preservation
mitochondrial
function,
attenuation
inflammatory
responses.
Collectively,
these
findings
highlight
biocompatible
NCM's
potential
as
novel
cardioprotective
agent
offer
promising
strategy
managing
Language: Английский
SOD/CAT-biomimetic bioactive glass-ceramics nanozyme with intracellular oxygen supply and immunoregulation for MRSA-infected wound repair
Tian Jing,
No information about this author
Yanzi Zhao,
No information about this author
Qingsong Zhang
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 162671 - 162671
Published: April 1, 2025
Language: Английский
Targeted intervention in obesity-associated atrial fibrosis using nanoparticle-loaded fusion protein
APOPTOSIS,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 25, 2025
Language: Английский
Review of Metal–Polyphenol Self-Assembled Nanoparticles: Synthesis, Properties, and Biological Applications in Inflammatory Diseases
ACS Biomaterials Science & Engineering,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 25, 2025
Polyphenols,
which
are
compounds
characterized
by
the
presence
of
phenolic
hydroxyl
groups,
abundantly
found
in
natural
plants
and
exist
highly
complex
forms
within
living
organisms.
As
some
most
prevalent
nature,
polyphenols
possess
significant
medicinal
value
due
to
their
unique
structural
features,
particularly
therapeutic
efficacy
antitumor,
anti-inflammatory,
antibacterial
applications.
In
context
inflammation
therapy,
polyphenolic
can
inhibit
excessive
release
inflammatory
mediators
from
cells,
thereby
mitigating
inflammation.
Furthermore,
these
exhibit
strong
antioxidant
properties,
enabling
them
scavenge
free
radicals
reactive
oxygen
species
(ROS),
reduce
oxidative
stress-related
damage,
exert
anti-inflammatory
effects.
Due
multiple
groups
ability
chelate
various
metals,
extensively
utilized
synthesis
self-assembled
nanoparticles
for
treatment
diseases.
Numerous
studies
have
demonstrated
that
profile
formed
through
self-assembly
with
metal
ions
surpasses
alone.
This
Review
will
focus
on
different
generate
nanoparticles,
characterization,
applications
inflammation-related
diseases,
providing
researchers
new
insights
into
synthetic
study
metal-polyphenol
nanocomposites
biological
Language: Английский